Loading...
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY
Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...
Na minha lista:
| Udgivet i: | Acta Endocrinol (Buchar) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Acta Endocrinologica Foundation
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/ https://ncbi.nlm.nih.gov/pubmed/31149244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|